Ads
related to: squamous cell carcinoma treatment- Patient Quality of Life
View Patient Quality of Life Data
After Undergoing a GBM Treatment.
- View 5-Year Efficacy Data
TTFields Long-Term Efficacy Data is
Available. Click to Learn More.
- GBM Patient Resources
Download Brochures and Treatment
Support Docs for Your GBM Patients.
- What is TTFields Therapy?
Access Information on How TTFields
are Being Used for GBM Treatment.
- GBM Patient Buddy Program
GBM Patients Can Sign Up & Connect
to Experienced Users & Caregivers.
- Video Library
Watch Videos from Experts & Hear
GBM Patient Treatment Experiences.
- Patient Quality of Life
Search results
MD Anderson Research Highlights for June 5, 2024 | Newswise
Newswise· 3 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 2 days agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...
Molecular Templates reports progress in cancer therapy trials By Investing.com
Investing.com· 5 days agoMolecular Templates, Inc. (NASDAQ:MTEM), a clinical-stage biopharmaceutical company, has announced...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 5 days agoWith a median follow-up of approximately three years (34.9 months), adjuvant treatment with mRNA-4157 (V940) in combination with Keytruda continued to demonstrate a clinically ...
A Bird’s Eye View of the Tumor Microenvironment
The Scientist· 5 days ago“One of the important things we as a field need to do is start really understanding what’s going on immunologically in the tumor in order to make treatment decisions,” said ...
Case Study: Patient with Rare Breast Cancer Has Surprising Response to NAC
MedPage Today· 3 days ago"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey ...
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives $66.29 Consensus Target Price from Analysts
ETF DAILY NEWS· 1 day agoJanux Therapeutics, Inc. (NASDAQ:JANX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight brokerages that are presently covering the firm, MarketBeat reports ...
DermaSensor COO on bringing skin cancer detection device to market - South Florida Business Journal
The Business Journals· 3 days agoAfter years of development, DermaSensor's handheld skin cancer detection tool is now in the hands of...
Promising HPV Cancer Treatment Advances in Clinical Trial By Investing.com
Investing.com· 4 days agoHOOKIPA Pharma Inc. (NASDAQ: HOOK), a clinical-stage biopharmaceutical company, has reported...
Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion...
Char-Koosta News· 6 days agoMore updated data from the Phase 1 study including in non-small cell lung cancer will be presented...
